Zhenyu Zhu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Chemotherapy Induced

Prognostic Factors

Cross Sectional

Top Venues

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Chengpei Zhu, Hu Li, Xiaobo Yang, Shanshan Wang, Yunchao Wang, Nan Zhang, Yanyu Wang, Jingnan Xue, Longhao Zhang, Cong Ning, Xu Yang, Ziyu Xun, Jiashuo Chao, Junyu Long, Xin-Ting Sang, Zhenyu Zhu, Haitao Zhao
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study. Cancer immunology, immunotherapy : CII (2023)